• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶剂和铜离子诱导的吡啶基吡唑-3-酮衍生物的合成:晶体结构、细胞毒性。

Solvent and Copper Ion-Induced Synthesis of Pyridyl-Pyrazole-3-One Derivatives: Crystal Structure, Cytotoxicity.

机构信息

Guangxi Key Laboratory of Electrochemical and Magnetochemical Functional Materials, Collaborative Innovation Center for Exploration of Hidden Nonferrous Metal Deposits and Development of New Materials in Guangxi (College of Chemistry and Bioengineering), Guilin University of Technology, Guilin 541004, China.

College of Chemistry and Engineering, Guangxi Normal University for Nationalities, Chongzuo 532200, China.

出版信息

Molecules. 2017 Oct 25;22(11):1813. doi: 10.3390/molecules22111813.

DOI:10.3390/molecules22111813
PMID:29068409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6150270/
Abstract

Five novel compounds, methyl 5-(acetyloxy)-1-(6-bromo-2-pyridinyl)-1-pyrazole-3-carboxylate (), methyl 1-(6-bromo-2-pyridinyl)-5-hydroxy-1H-pyrazole-3-carboxylate (), Trimethyl 1,1',1''-tris(6-bromo-2-pyridinyl)-5,5''-dihydroxy-5'-oxo-1',5'-dihydro-1H,1''H-4,4': 4',4''-terpyrazole-3,3',3''-tricarboxylate (H₂L¹, ), [Cu₂(L²)₂]·CH₃OH (), H₂L·CH₃CN () were synthesized. Compounds - characterized by elemental analysis, IR, and X-ray single-crystal diffraction. And - were also characterized by ¹H NMR, C NMR and ESI-MS. The H₂L¹, H₂L² were formed by in-situ reaction. H₂L² and H₂L are mesomer compounds which have two chiral carbons. The antitumor activity of compounds - against BEL-7404, HepG2, NCI-H460, T-24, A549 tumor cell lines were screened by methylthiazolyl tetrozolium (MTT) assay. The compounds , showed weakly growth inhibition on the HepG2 cell lines. The HepG2 and A549 cell lines showed higher sensitivity to compound , while the IC values are 10.66, 28.09 μM, respectively. It is worth noting that compounds - did not show cytotoxicity to human normal liver cell line HL-7702, suggesting its cytotoxic selectivity on these tumor cell lines.

摘要

合成了五个新化合物,分别为 5-(乙酰氧基)-1-(6-溴吡啶-2-基)-1-吡唑-3-羧酸甲酯 ()、1-(6-溴吡啶-2-基)-5-羟基-1H-吡唑-3-羧酸甲酯 ()、1,1',1''-三(6-溴吡啶-2-基)-5,5''-二羟基-5'-氧代-1',5'-二氢-1H,1''H-4,4':4',4''-三联吡唑-3,3',3''-三羧酸甲酯 (H₂L¹, )、[Cu₂(L²)₂]·CH₃OH ()、H₂L·CH₃CN ()。通过元素分析、红外光谱和 X 射线单晶衍射对化合物 - 进行了表征。通过 ¹H NMR、C NMR 和 ESI-MS 对化合物 - 进行了表征。H₂L¹、H₂L²是通过原位反应形成的。H₂L²和 H₂L 是具有两个手性碳原子的mesomer 化合物。通过甲基噻唑基四唑 (MTT) 法筛选了化合物 - 对 BEL-7404、HepG2、NCI-H460、T-24、A549 肿瘤细胞系的抗肿瘤活性。化合物 、 对 HepG2 细胞系表现出较弱的生长抑制作用。HepG2 和 A549 细胞系对化合物 表现出较高的敏感性,IC 值分别为 10.66、28.09 μM。值得注意的是,化合物 - 对人正常肝细胞系 HL-7702 没有表现出细胞毒性,表明其对这些肿瘤细胞系具有细胞毒性选择性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/6cdb6859a2bc/molecules-22-01813-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/a699b99cad62/molecules-22-01813-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/186436912eca/molecules-22-01813-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/627cb0339498/molecules-22-01813-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/9a74c60ee2ba/molecules-22-01813-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/b020b52f0271/molecules-22-01813-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/0d31c8812ce5/molecules-22-01813-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/6cdb6859a2bc/molecules-22-01813-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/a699b99cad62/molecules-22-01813-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/186436912eca/molecules-22-01813-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/627cb0339498/molecules-22-01813-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/9a74c60ee2ba/molecules-22-01813-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/b020b52f0271/molecules-22-01813-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/0d31c8812ce5/molecules-22-01813-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71e/6150270/6cdb6859a2bc/molecules-22-01813-g005.jpg

相似文献

1
Solvent and Copper Ion-Induced Synthesis of Pyridyl-Pyrazole-3-One Derivatives: Crystal Structure, Cytotoxicity.溶剂和铜离子诱导的吡啶基吡唑-3-酮衍生物的合成:晶体结构、细胞毒性。
Molecules. 2017 Oct 25;22(11):1813. doi: 10.3390/molecules22111813.
2
Synthesis, crystal structure and biological evaluation of a new dasatinib copper(II) complex as telomerase inhibitor.一种新型达沙替尼铜(II)配合物作为端粒酶抑制剂的合成、晶体结构及生物学评价
Eur J Med Chem. 2018 Jan 1;143:1597-1603. doi: 10.1016/j.ejmech.2017.10.058. Epub 2017 Oct 25.
3
Pyrazolone incorporating bipyridyl metallointercalators as effective DNA, protein and lung cancer targets: Synthesis, characterization and in vitro biocidal evaluation.含吡唑啉酮的双吡啶金属嵌入剂作为有效的 DNA、蛋白质和肺癌靶点:合成、表征和体外杀菌评价。
Chem Biol Interact. 2015 Oct 5;240:250-66. doi: 10.1016/j.cbi.2015.08.022. Epub 2015 Sep 2.
4
Synthesis, crystal structure and antitumor effect of a novel copper(II) complex bearing zoledronic acid derivative.一种新型含唑来膦酸衍生物的铜(II)配合物的合成、晶体结构及抗肿瘤作用
Eur J Med Chem. 2015 Jan 7;89:42-50. doi: 10.1016/j.ejmech.2014.10.028. Epub 2014 Oct 13.
5
Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.新型 2-(5-(羟甲基)-3-苯基-1H-吡唑-1-基)-1-苯乙醇衍生物的合成、晶体结构和生物评价。
Eur J Med Chem. 2010 Dec;45(12):5792-9. doi: 10.1016/j.ejmech.2010.09.041. Epub 2010 Oct 1.
6
Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.新型1-芳基甲基-3-芳基-1H-吡唑-5-碳酰肼衍生物作为抗A549肺癌细胞潜在药物的合成及其构效关系
Bioorg Med Chem. 2007 Nov 15;15(22):6893-9. doi: 10.1016/j.bmc.2007.08.021. Epub 2007 Aug 21.
7
Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.具有改良吲哚并[3,2-c]喹啉配体的高细胞毒性铜(II)配合物的构效关系。
Inorg Chem. 2010 Dec 6;49(23):11084-95. doi: 10.1021/ic101633z. Epub 2010 Oct 27.
8
Synthesis of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives and their inhibition against growth of A549 and H322 lung cancer cells.新型吡唑并[1,5-a]吡嗪-4(5H)-酮衍生物的合成及其对 A549 和 H322 肺癌细胞生长的抑制作用。
Bioorg Med Chem Lett. 2011 Jul 1;21(13):3909-13. doi: 10.1016/j.bmcl.2011.05.035. Epub 2011 May 15.
9
Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.铜(II)配合物对噻唑烷酮-哌嗪和噻唑烷酮-吗啉杂化物的抗增殖活性有很强的影响。
Dalton Trans. 2015 May 21;44(19):9071-90. doi: 10.1039/c5dt01076d.
10
A novel methodology for synthesis of dihydropyrazole derivatives as potential anticancer agents.一种合成二氢吡唑衍生物作为潜在抗癌剂的新方法。
Org Biomol Chem. 2014 Apr 7;12(13):2028-32. doi: 10.1039/c3ob42432d. Epub 2014 Feb 12.

引用本文的文献

1
Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.吡唑衍生物的合成及药理活性研究进展。
Molecules. 2018 Jan 12;23(1):134. doi: 10.3390/molecules23010134.

本文引用的文献

1
Preparation of 4-([2,2':6',2″-terpyridin]-4'-yl)-N,N-diethylaniline Ni(II) and Pt(II) complexes and exploration of their in vitro cytotoxic activities.4-([2,2':6',2″-三联吡啶]-4'-基)-N,N-二乙苯胺镍(II)和铂(II)配合物的制备及其体外细胞毒性活性的探究
Eur J Med Chem. 2016 Jan 27;108:1-12. doi: 10.1016/j.ejmech.2015.11.005. Epub 2015 Nov 14.
2
Crystal structure refinement with SHELXL.使用SHELXL进行晶体结构精修。
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8. doi: 10.1107/S2053229614024218. Epub 2015 Jan 1.
3
Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties.
含吡唑基团的新型咪唑并[2,1-b]噻唑衍生物的合成、体外抗癌评估及计算机模拟研究
Eur J Med Chem. 2014 Mar 21;75:492-500. doi: 10.1016/j.ejmech.2013.12.010. Epub 2014 Jan 23.
4
Exploration of the medical periodic table: towards new targets.医学元素周期表的探索:寻求新靶点。
Chem Commun (Camb). 2013 Jun 7;49(45):5106-31. doi: 10.1039/c3cc41143e.
5
Membrane localized iridium(III) complex induces endoplasmic reticulum stress and mitochondria-mediated apoptosis in human cancer cells.膜定位铱(III)配合物诱导人癌细胞内质网应激和线粒体介导的细胞凋亡。
J Med Chem. 2013 May 9;56(9):3636-44. doi: 10.1021/jm4001665. Epub 2013 Apr 25.
6
Regression of lung cancer by hypoxia-sensitizing ruthenium polypyridyl complexes.缺氧增敏型钌多吡啶配合物抑制肺癌的研究进展。
Mol Cancer Ther. 2013 May;12(5):643-53. doi: 10.1158/1535-7163.MCT-12-1130. Epub 2013 Feb 26.
7
In vitro and in vivo anticancer activity of copper bis(thiosemicarbazone) complexes.铜双(硫代氨基甲酰)配合物的体外和体内抗癌活性。
J Med Chem. 2013 Feb 14;56(3):722-34. doi: 10.1021/jm300938r. Epub 2013 Jan 30.
8
Synthesis, structures, and antimalarial activities of some silver(I), gold(I) and gold(III) complexes involving N-heterocyclic carbene ligands.含 N-杂环卡宾配体的一些银(I)、金(I)和金(III)配合物的合成、结构和抗疟活性。
Eur J Med Chem. 2013 Feb;60:64-75. doi: 10.1016/j.ejmech.2012.11.038. Epub 2012 Dec 7.
9
Synthesis, crystal structure, cytotoxicity and DNA interaction of 5,7-dichloro-8-quinolinolato-lanthanides.5,7-二氯-8-喹啉醇基-镧系元素的合成、晶体结构、细胞毒性和 DNA 相互作用。
Eur J Med Chem. 2013 Jan;59:194-202. doi: 10.1016/j.ejmech.2012.10.037. Epub 2012 Nov 12.
10
Copper-dependent cytotoxicity of 8-hydroxyquinoline derivatives correlates with their hydrophobicity and does not require caspase activation.8-羟基喹啉衍生物的铜依赖性细胞毒性与其疏水性相关,且不需要半胱天冬酶的激活。
J Med Chem. 2012 Dec 13;55(23):10448-59. doi: 10.1021/jm301053a. Epub 2012 Dec 3.